What's Happening?
Researchers at ETH Zurich have developed a new dietary supplement to efficiently treat iron deficiency and anemia. The supplement consists of oat protein nanofibrils coated with iron nanoparticles, which
are absorbed by the body almost twice as well as traditional iron sulphate supplements. Clinical trials in Thailand showed significant improvement in anemia symptoms among women treated with the new compound.
Why It's Important?
Iron deficiency is a widespread issue, particularly affecting women, and can lead to anemia, fatigue, and weakened immunity. The development of a more effective and palatable iron supplement could improve treatment outcomes and patient compliance. This innovation is particularly beneficial for vegetarians and vegans, who may struggle to meet their iron needs through diet alone.
What's Next?
The researchers aim to further develop the technology to address other deficiencies, such as zinc and selenium. The new supplement could soon be available as a dietary option, offering a more accessible and effective solution for those suffering from iron deficiency. Stakeholders in the health and nutrition industry may explore partnerships to bring this product to market.
